Published in Brain Behav Immun on September 05, 2006
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. Brain Behav Immun (2010) 1.61
Association of the physiological stress response with depressive symptoms in patients with breast cancer. Psychosom Med (2014) 1.52
Impact of stress on cancer metastasis. Future Oncol (2010) 1.52
Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol (2010) 1.47
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol (2014) 1.40
Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med (2011) 1.32
Neuroendocrine influences on cancer progression. Brain Behav Immun (2012) 1.15
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav Immun (2008) 1.13
Surviving recurrence: psychological and quality-of-life recovery. Cancer (2008) 1.08
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother (2008) 1.08
Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program is associated with increased natural killer cell activity. J Altern Complement Med (2010) 1.05
Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer (2010) 1.05
Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am (2011) 1.04
Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. Am Psychol (2015) 0.94
Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun (2010) 0.92
Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer. Brain Behav Immun (2012) 0.86
Comparison of groups with different patterns of symptom cluster intensity across the breast cancer treatment trajectory. Cancer Nurs (2014) 0.84
Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer (2012) 0.83
Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations. Brain Behav Immun (2013) 0.82
Impact of breast cancer recurrence and cancer-specific stress on spouse health and immune function. Brain Behav Immun (2011) 0.81
Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress. Brain Behav Immun (2010) 0.80
Cancer-specific stress and mood disturbance: implications for symptom perception, quality of life, and immune response in women shortly after diagnosis of breast cancer. ISRN Nurs (2012) 0.79
COMT Diplotype Amplifies Effect of Stress on Risk of Temporomandibular Pain. J Dent Res (2015) 0.79
Construct validation of self-reported stress scales. Psychol Assess (2013) 0.77
Mindfulness based stress reduction study design of a longitudinal randomized controlled complementary intervention in women with breast cancer. BMC Complement Altern Med (2013) 0.76
Mindfulness and its efficacy for psychological and biological responses in women with breast cancer. Cancer Med (2017) 0.75
Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 Years. Clin Cancer Res (2016) 0.75
Early Childhood Adversity and its Associations With Anxiety, Depression, and Distress in Women With Breast Cancer. Psychosomatics (2015) 0.75
A global measure of perceived stress. J Health Soc Behav (1983) 56.90
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull (2004) 8.52
Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst (1998) 3.77
The perseverative cognition hypothesis: a review of worry, prolonged stress-related physiological activation, and health. J Psychosom Res (2006) 3.49
In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A (2000) 2.76
Cytokine-induced sickness behavior. Brain Behav Immun (2003) 2.70
Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol (2004) 2.56
Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol (2004) 2.55
Stress and immunity in humans: a meta-analytic review. Psychosom Med (1993) 2.52
Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat (1996) 2.35
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol (2002) 2.10
Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun (2003) 1.81
A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry (1990) 1.71
Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol (2002) 1.52
Expanding stress theory: prolonged activation and perseverative cognition. Psychoneuroendocrinology (2005) 1.45
Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods (1992) 1.44
Natural killer cells and cancer. Cancer (1996) 1.33
Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol (2001) 1.32
Evidence that secretory IgA antibody is associated with daily mood. J Pers Soc Psychol (1987) 1.30
Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol (1991) 1.26
Personality and the immune system: models, methods, and mechanisms. Ann Behav Med (2000) 1.20
Natural mechanisms protecting against cancer. Immunol Lett (2003) 1.11
Assessing stress in cancer patients: a second-order factor analysis model for the Perceived Stress Scale. Assessment (2004) 1.05
Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol (2002) 1.04
Individual differences, immunity, and cancer: lessons from personality psychology. Brain Behav Immun (2003) 1.01
Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res (1997) 1.01
Coping with cancer during the first year after diagnosis. Assessment and intervention. Cancer (1992) 1.00
The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiology (1999) 0.96
A presurgical psychosocial intervention for breast cancer patients. psychological distress and the immune response. J Psychosom Res (2000) 0.91
Mood change and immune status of human subjects in a 10-day confinement study. Aviat Space Environ Med (2005) 0.83
Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention? Crit Rev Oncol Hematol (2005) 0.81
Psychoneuroimmunology examined: The role of subjective stress. Cellscience (2006) 0.80
Slow-reacting immunoglobulin in relation to social support and changes in job strain: a preliminary note. Psychosom Med (1991) 0.80
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer (2008) 3.68
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. J Clin Oncol (2011) 2.87
Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol (2004) 2.55
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Res (2010) 1.76
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest (2002) 1.74
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood (2004) 1.73
Giant breast tumors: surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature. World J Surg Oncol (2008) 1.73
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clin Cancer Res (2007) 1.66
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res (2011) 1.61
Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun (2007) 1.59
Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol (2006) 1.58
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res (2004) 1.55
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies. Mol Cancer Ther (2009) 1.54
Association of the physiological stress response with depressive symptoms in patients with breast cancer. Psychosom Med (2014) 1.52
When fit indices and residuals are incompatible. Psychol Methods (2002) 1.51
β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav Immun (2012) 1.50
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol (2007) 1.49
Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psychooncology (2004) 1.48
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy. Cancer Immunol Immunother (2011) 1.47
Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.44
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst (2004) 1.42
Traumatic stress, perceived global stress, and life events: prospectively predicting quality of life in breast cancer patients. Health Psychol (2005) 1.38
Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One (2007) 1.36
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res (2006) 1.32
Breast cancer survivors' health-related quality of life : racial differences and comparisons with noncancer controls. Cancer (2008) 1.28
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer (2010) 1.27
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood (2008) 1.26
PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress (2008) 1.25
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production. J Immunol (2011) 1.25
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol (2007) 1.23
The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Health Psychol (2010) 1.22
A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med (2009) 1.22
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab. Breast Cancer Res Treat (2008) 1.21
Review of S100A9 biology and its role in cancer. Biochim Biophys Acta (2012) 1.19
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest (2003) 1.17
Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells. Clin Cancer Res (2007) 1.16
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J Immunol (2005) 1.15
Social and cultural factors are related to perceived colorectal cancer screening benefits and intentions in African Americans. J Behav Med (2009) 1.15
Informal caregiving for cancer patients. Cancer (2013) 1.14
Cellular immunity in breast cancer patients completing taxane treatment. Clin Cancer Res (2004) 1.13
IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis. Cancer Res (2008) 1.11
Surviving recurrence: psychological and quality-of-life recovery. Cancer (2008) 1.08
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother (2008) 1.08
Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med (2010) 1.07
Melanoma, version 4.2014. J Natl Compr Canc Netw (2014) 1.07
Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients. Psychooncology (2012) 1.05
Assessing stress in cancer patients: a second-order factor analysis model for the Perceived Stress Scale. Assessment (2004) 1.05
Myeloid-derived suppressor cells in breast cancer. Breast Cancer Res Treat (2013) 1.04
Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cell Immunol (2011) 1.03
STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol Immunother (2007) 1.03
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.02
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res (2002) 1.02
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors. J Clin Oncol (2009) 1.02
Sexual self schema as a moderator of sexual and psychological outcomes for gynecologic cancer survivors. Arch Sex Behav (2008) 1.02
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha. Clin Cancer Res (2008) 1.02
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J Clin Oncol (2012) 1.01
Hopelessness as a predictor of depressive symptoms for breast cancer patients coping with recurrence. Psychooncology (2009) 1.01
Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Clin Cancer Res (2006) 1.00
Mismatch of posttraumatic stress disorder (PTSD) symptoms and DSM-IV symptom clusters in a cancer sample: exploratory factor analysis of the PTSD Checklist-Civilian Version. J Trauma Stress (2005) 1.00
Stress and quality of life in breast cancer recurrence: moderation or mediation of coping? Ann Behav Med (2008) 0.99
Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol (2006) 0.99
Strategies used in coping with a cancer diagnosis predict meaning in life for survivors. Health Psychol (2006) 0.98
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease. Cancer Immunol Immunother (2014) 0.97
IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma. J Immunol (2004) 0.97
The role of sexual self-schema in a diathesis-stress model of sexual dysfunction. Appl Prev Psychol (1999) 0.96
Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy. Cancer Immunol Immunother (2005) 0.96
Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy. Clin Cancer Res (2010) 0.96
Religious Practice and Spirituality in the Psychological Adjustment of Survivors of Breast Cancer. Couns Values (2009) 0.95
Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines. Surgery (2012) 0.95
Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention. J Consult Clin Psychol (2011) 0.94
Delayed emotional recovery after taxane-based chemotherapy. Cancer (2008) 0.93
Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors. J Surg Res (2007) 0.93
Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer Res (2005) 0.93
A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma. J Immunother (2011) 0.93
Fatigue and herpesvirus latency in women newly diagnosed with breast cancer. Brain Behav Immun (2011) 0.93
Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast (2013) 0.92
Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery. World J Surg Oncol (2007) 0.92
Physical sequelae and depressive symptoms in gynecologic cancer survivors: meaning in life as a mediator. Ann Behav Med (2008) 0.92
Meaning in life mediates the relationship between social and physical functioning and distress in cancer survivors. Br J Health Psychol (2007) 0.92
Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer. Health Psychol (2011) 0.92
The gynecologic oncology consult: symptom presentation and concurrent symptoms of depression and anxiety. Obstet Gynecol (2004) 0.92
Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol (2013) 0.91
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation. Proc Natl Acad Sci U S A (2014) 0.91
Melanoma. J Natl Compr Canc Netw (2012) 0.90
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12. J Clin Oncol (2005) 0.90
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation. J Immunother (2012) 0.90
Body change stress for women with breast cancer: the Breast-Impact of Treatment Scale. Ann Behav Med (2006) 0.89
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. Blood (2006) 0.89
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Exp Eye Res (2012) 0.89
Sexual morbidity associated with poorer psychological adjustment among gynecological cancer survivors. Int J Gynecol Cancer (2010) 0.89